For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $26.97 in the prior trading day, Twist Bioscience Corp (NASDAQ: TWST) closed at $27.95, up 3.63%. In other words, the price has increased by $3.63 from its previous closing price. On the day, 1.63 million shares were traded. TWST stock price reached its highest trading level at $28.45 during the session, while it also had its lowest trading level at $27.58.
Ratios:
Our goal is to gain a better understanding of TWST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.90. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The Stock’s future direction. In the most recent recommendation for this company, Wolfe Research on December 13, 2024, initiated with a Outperform rating and assigned. The Stock a target price of $60.
On June 04, 2024, Guggenheim started tracking. The Stock assigning a Buy rating and target price of $53. Goldman Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for. The Stock was revised from $25 to $45.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 15 ’25 when Cho Dennis sold 94 shares for $25.33 per share. The transaction valued at 2,381 led to the insider holds 102,943 shares of the business.
Cho Dennis bought 94 shares of TWST for $2,381 on Sep 15 ’25. On Sep 08 ’25, another insider, Cho Dennis, who serves as the insider of the company, sold 269 shares for $25.76 each. As a result, the insider received 6,929 and left with 103,037 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TWST now has a Market Capitalization of 1687087872 and an Enterprise Value of 1529439872. For. The Stock, the TTM Price-to-Sale (P/S) ratio is 4.66 while its Price-to-Book (P/B) ratio in mrq is 3.52. Its current Enterprise Value per Revenue stands at 4.222 whereas that against EBITDA is -12.803.
Stock Price History:
The Beta on a monthly basis for TWST is 2.39, which has changed by -0.39814812 over the last 52 weeks, in comparison to a change of 0.16298151 over the same period for the S&P500. Over the past 52 weeks, TWST has reached a high of $55.33, while it has fallen to a 52-week low of $24.07. The 50-Day Moving Average of. The Stock is -6.52%, while the 200-Day Moving Average is calculated to be -26.81%.
Shares Statistics:
. The Stock has traded on average 1.43M shares per day over the past 3-months and 1799780 shares per day over the last 10 days, according to various share statistics. A total of 60.17M shares are outstanding, with a floating share count of 57.63M. Insiders hold about 4.53% of the company’s shares, while institutions hold 113.35% stake in the company. Shares short for TWST as of 1756425600 were 10234719 with a Short Ratio of 7.17, compared to 1753920000 on 10437018. Therefore, it implies a Short% of Shares Outstanding of 10234719 and a Short% of Float of 19.129999.
Earnings Estimates
The company has 1.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.52 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.34 and -$1.34 for the fiscal current year, implying an average EPS of -$1.34. EPS for the following year is -$1.76, with 1.0 analysts recommending between -$1.76 and -$1.76.
Revenue Estimates
6 analysts predict $97.38M in revenue for the current quarter. It ranges from a high estimate of $97.96M to a low estimate of $97M. As of the current estimate, Twist Bioscience Corp’s year-ago sales were $84.71MFor the next quarter, 6 analysts are estimating revenue of $101.39M. There is a high estimate of $103.3M for the next quarter, whereas the lowest estimate is $100M.
A total of 6 analysts have provided revenue estimates for TWST’s current fiscal year. The highest revenue estimate was $375.52M, while the lowest revenue estimate was $374M, resulting in an average revenue estimate of $374.89M. In the same quarter a year ago, actual revenue was $312.97MBased on 6 analysts’ estimates, the company’s revenue will be $441.55M in the next fiscal year. The high estimate is $445.92M and the low estimate is $436M.
